Algorhythm Holdings reports May 14 results carrying one of the most aggressive short positions in its peer group, with shorts holding nearly 40% of the free float heading into the print.
The short positioning is the dominant story here. Nearly 40% of RIME's free float is short — a level that keeps this stock in genuinely contested territory. That figure ticked up another 7.5% in a single session on May 11, pushing short shares to roughly 1.06 million. The ORTEX short score of 70.7 reflects the same pressure, running near its highest level of the past two weeks. Borrow costs have eased from their April peak — cost to borrow was above 40% in early April and has since pulled back to around 22% — signalling that the most acute borrow squeeze has passed but conditions remain far from comfortable for new shorts entering the name.
The stock itself has been volatile and mostly lower. RIME closed at $0.76, down 28% over the past month, before a sharp 25% single-session bounce on May 12 cut some of that loss. Over the trailing week it is still down 13%. With a market cap of roughly $8.9 million, this is a micro-cap with thin liquidity, and price moves of this magnitude can reflect modest share volumes. The RSI14 of 24.8 marks deeply oversold territory — the bounce on May 12 may partly reflect technical positioning rather than a fundamental catalyst. The only analyst coverage on record — an initiation from Litchfield Hills in June 2025 at a $5 Buy — is nearly a year old and should not be treated as current guidance at a $0.76 stock price.
The most recent earnings event offers a cautionary data point. At the April 2 release, the stock fell 11.4% on the day and 13.6% over the subsequent five sessions. The prior event in April 2026 produced a 3.8% gain on the day, though that reversed for a modest positive five-day outcome. The pattern is asymmetric: down moves have been sharper than up moves. Institutional ownership is minimal — Vanguard and Geode hold token positions, and the largest named holders are individuals with small stakes. That thin ownership base amplifies the stock's sensitivity to short-covering flows or any catalyst that forces position changes.
Tomorrow's print will test whether RIME can deliver anything operationally that justifies fresh capital at current levels — or whether 40%-of-float short interest and a deeply oversold chart are simply pricing in the probability that it cannot.
See the live data behind this article on ORTEX.
Open RIME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
